0001209191-19-026865.txt : 20190501 0001209191-19-026865.hdr.sgml : 20190501 20190501183720 ACCESSION NUMBER: 0001209191-19-026865 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190501 FILED AS OF DATE: 20190501 DATE AS OF CHANGE: 20190501 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HUBBARD ROBERT GLENN CENTRAL INDEX KEY: 0001283051 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-15787 FILM NUMBER: 19789140 MAIL ADDRESS: STREET 1: 100 BELLEVUE PARKWAY CITY: WILMINGTON STATE: DE ZIP: 19809 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: METLIFE INC CENTRAL INDEX KEY: 0001099219 STANDARD INDUSTRIAL CLASSIFICATION: LIFE INSURANCE [6311] IRS NUMBER: 134075851 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 PARK AVENUE CITY: NEW YORK STATE: NY ZIP: 10166 BUSINESS PHONE: 212-578-5500 MAIL ADDRESS: STREET 1: 200 PARK AVENUE CITY: NEW YORK STATE: NY ZIP: 10166 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-05-01 0 0001099219 METLIFE INC MET 0001283051 HUBBARD ROBERT GLENN METLIFE, INC., 200 PARK AVENUE NEW YORK NY 10166 1 0 0 0 Common Stock 54361 D Deferred Share Equivalents 2019-05-01 4 A 0 283 45.71 A Common Stock 283 22559 D The Reporting Person previously chose to defer his cash fees under the MetLife Deferred Compensation Plan for Non-Management Directors. The Reporting Person chose simulated investment in MetLife, Inc. common stock for a portion of those deferred cash fees. As a result, the Reporting Person acquired the Deferred Share Equivalents reported here. Each Deferred Share Equivalent (formerly referred to as Common Stock Equivalent Units) is the economic value of one share of MetLife, Inc. common stock. Deferred Share Equivalents are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. The Reporting Person, a non-management director of MetLife, Inc., became Chairman of the Board of Directors on May 1, 2019. He previously served as Lead Director. Under MetLife, Inc.'s non-management director compensation arrangements, the Reporting Person's Board Chair cash fees for May 1 through June 17, 2019 became due on May 1. The Company reduced the amount due by the amount it previously paid the Reporting Person as Lead Director cash retainer fees for the same period. /s/ Mark A. Schuman, authorized person 2019-05-01